BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17942929)

  • 1. Thymic stromal-derived lymphopoietin induces proliferation of pre-B leukemia and antagonizes mTOR inhibitors, suggesting a role for interleukin-7Ralpha signaling.
    Brown VI; Hulitt J; Fish J; Sheen C; Bruno M; Xu Q; Carroll M; Fang J; Teachey D; Grupp SA
    Cancer Res; 2007 Oct; 67(20):9963-70. PubMed ID: 17942929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis.
    Francis OL; Milford TA; Martinez SR; Baez I; Coats JS; Mayagoitia K; Concepcion KR; Ginelli E; Beldiman C; Benitez A; Weldon AJ; Arogyaswamy K; Shiraz P; Fisher R; Morris CL; Zhang XB; Filippov V; Van Handel B; Ge Z; Song C; Dovat S; Su RJ; Payne KJ
    Haematologica; 2016 Apr; 101(4):417-26. PubMed ID: 26611474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling.
    Rochman Y; Kashyap M; Robinson GW; Sakamoto K; Gomez-Rodriguez J; Wagner KU; Leonard WJ
    Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19455-60. PubMed ID: 20974963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism.
    Levin SD; Koelling RM; Friend SL; Isaksen DE; Ziegler SF; Perlmutter RM; Farr AG
    J Immunol; 1999 Jan; 162(2):677-83. PubMed ID: 9916685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSLP or IL-7 provide an IL-7Rα signal that is critical for human B lymphopoiesis.
    Milford TA; Su RJ; Francis OL; Baez I; Martinez SR; Coats JS; Weldon AJ; Calderon MN; Nwosu MC; Botimer AR; Suterwala BT; Zhang XB; Morris CL; Weldon DJ; Dovat S; Payne KJ
    Eur J Immunol; 2016 Sep; 46(9):2155-61. PubMed ID: 27325567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSLP as a Potential Therapy in the Treatment of CRLF2 B Cell Acute Lymphoblastic Leukemia.
    Alkashgari HR; Ruiz-Jimenez C; Stoian C; Coats JS; Baez I; Chirshev E; Martinez SR; Dovat S; Francis-Boyle OL; Casiano CA; Payne KJ
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymic stromal lymphopoietin induces early human B-cell proliferation and differentiation.
    Scheeren FA; van Lent AU; Nagasawa M; Weijer K; Spits H; Legrand N; Blom B
    Eur J Immunol; 2010 Apr; 40(4):955-65. PubMed ID: 20127673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction.
    Isaksen DE; Baumann H; Trobridge PA; Farr AG; Levin SD; Ziegler SF
    J Immunol; 1999 Dec; 163(11):5971-7. PubMed ID: 10570284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia.
    Tasian SK; Doral MY; Borowitz MJ; Wood BL; Chen IM; Harvey RC; Gastier-Foster JM; Willman CL; Hunger SP; Mullighan CG; Loh ML
    Blood; 2012 Jul; 120(4):833-42. PubMed ID: 22685175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-7Rα Expression Regulates Murine Dendritic Cell Sensitivity to Thymic Stromal Lymphopoietin.
    Kummola L; Ortutay Z; Chen X; Caucheteux S; Hämäläinen S; Aittomäki S; Yagi R; Zhu J; Pesu M; Paul WE; Junttila IS
    J Immunol; 2017 May; 198(10):3909-3918. PubMed ID: 28404633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSLP signaling network revealed by SILAC-based phosphoproteomics.
    Zhong J; Kim MS; Chaerkady R; Wu X; Huang TC; Getnet D; Mitchell CJ; Palapetta SM; Sharma J; O'Meally RN; Cole RN; Yoda A; Moritz A; Loriaux MM; Rush J; Weinstock DM; Tyner JW; Pandey A
    Mol Cell Proteomics; 2012 Jun; 11(6):M112.017764. PubMed ID: 22345495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3.
    Nakayama J; Yamamoto M; Hayashi K; Satoh H; Bundo K; Kubo M; Goitsuka R; Farrar MA; Kitamura D
    Blood; 2009 Feb; 113(7):1483-92. PubMed ID: 19047679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation.
    Quentmeier H; Drexler HG; Fleckenstein D; Zaborski M; Armstrong A; Sims JE; Lyman SD
    Leukemia; 2001 Aug; 15(8):1286-92. PubMed ID: 11480573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncoupling of proliferation and Stat5 activation in thymic stromal lymphopoietin-mediated signal transduction.
    Isaksen DE; Baumann H; Zhou B; Nivollet S; Farr AG; Levin SD; Ziegler SF
    J Immunol; 2002 Apr; 168(7):3288-94. PubMed ID: 11907084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2.
    van Bodegom D; Zhong J; Kopp N; Dutta C; Kim MS; Bird L; Weigert O; Tyner J; Pandey A; Yoda A; Weinstock DM
    Blood; 2012 Oct; 120(14):2853-63. PubMed ID: 22915648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the mTOR signalling pathway is required for pancreatic growth in protease-inhibitor-fed mice.
    Crozier SJ; Sans MD; Guo L; D'Alecy LG; Williams JA
    J Physiol; 2006 Jun; 573(Pt 3):775-86. PubMed ID: 16613881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors.
    Cheng Y; Chikwava K; Wu C; Zhang H; Bhagat A; Pei D; Choi JK; Tong W
    J Clin Invest; 2016 Apr; 126(4):1267-81. PubMed ID: 26974155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered responses to homeostatic cytokines in patients with idiopathic CD4 lymphocytopenia.
    Bugault F; Benati D; Mouthon L; Landires I; Rohrlich P; Pestre V; Thèze J; Lortholary O; Chakrabarti LA
    PLoS One; 2013; 8(1):e55570. PubMed ID: 23383227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin.
    Ly C; Arechiga AF; Melo JV; Walsh CM; Ong ST
    Cancer Res; 2003 Sep; 63(18):5716-22. PubMed ID: 14522890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia.
    Maude SL; Tasian SK; Vincent T; Hall JW; Sheen C; Roberts KG; Seif AE; Barrett DM; Chen IM; Collins JR; Mullighan CG; Hunger SP; Harvey RC; Willman CL; Fridman JS; Loh ML; Grupp SA; Teachey DT
    Blood; 2012 Oct; 120(17):3510-8. PubMed ID: 22955920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.